Twist Historical Income Statement

TWST Stock

USD 46.40 4.17 9.87%

Historical analysis of Twist Bioscience income statement accounts such as Interest Expense of 27.6 K, Selling General Administrative of 124.4 M, Total Revenue of 328.6 M or Gross Profit of 140 M can show how well Twist Bioscience Corp performed in making a profits. Evaluating Twist Bioscience income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Twist Bioscience's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Twist Bioscience Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Twist Bioscience Corp is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About Twist Income Statement Analysis

Twist Bioscience Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Twist Bioscience shareholders. The income statement also shows Twist investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Twist Bioscience Income Statement Chart

At this time, Twist Bioscience's Income Tax Expense is comparatively stable compared to the past year. Reconciled Depreciation is likely to gain to about 33 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 283.1 M in 2024.

Selling General Administrative Total Revenue Other Operating Expenses Research Development

Total Revenue

Total revenue comprises all receipts Twist Bioscience Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Twist Bioscience Corp. It is also known as Twist Bioscience overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Twist Bioscience's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Twist Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	2.0M	29.3M	31.4M	33.0M
Interest Income	3.1M	14.4M	15.3M	16.1M

Depreciation And Amortization Interest Income

Twist Bioscience income statement Correlations

	Net Interest Income	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Reconciled Depreciation	Selling And Marketing Expenses	Non Operating Income Net Other	Non Recurring
Net Interest Income		1.0	0.96	-0.75	0.73	0.92	0.91	0.77	-0.78	-0.8	-0.76	0.69	-0.68	0.93	0.75	-0.79	0.75	-0.8	0.05	0.98	0.81	0.84	-0.76
Interest Income	1.0		0.96	-0.71	0.71	0.91	0.9	0.76	-0.77	-0.79	-0.74	0.66	-0.67	0.92	0.73	-0.77	0.73	-0.79	0.08	0.98	0.79	0.83	-0.77
Depreciation And Amortization	0.96	0.96		-0.73	0.65	0.87	0.86	0.7	-0.69	-0.73	-0.67	0.59	-0.57	0.88	0.66	-0.71	0.58	-0.73	0.21	0.94	0.8	0.68	-0.76
Interest Expense	-0.75	-0.71	-0.73		-0.75	-0.83	-0.85	-0.78	0.78	0.77	0.77	-0.81	0.73	-0.8	-0.78	0.77	-0.79	0.77	0.34	-0.83	-0.85	-0.65	0.53
Selling General Administrative	0.73	0.71	0.65	-0.75		0.9	0.89	0.99	-0.97	-0.96	-0.96	0.97	-0.95	0.9	1.0	-0.96	0.84	-0.96	-0.5	0.8	0.9	0.59	-0.37
Total Revenue	0.92	0.91	0.87	-0.83	0.9		1.0	0.91	-0.94	-0.96	-0.94	0.85	-0.89	1.0	0.9	-0.95	0.84	-0.96	-0.26	0.97	0.89	0.75	-0.73
Gross Profit	0.91	0.9	0.86	-0.85	0.89	1.0		0.9	-0.93	-0.95	-0.93	0.85	-0.88	0.99	0.89	-0.94	0.84	-0.95	-0.28	0.96	0.89	0.75	-0.74
Other Operating Expenses	0.77	0.76	0.7	-0.78	0.99	0.91	0.9		-0.96	-0.95	-0.94	0.97	-0.93	0.91	1.0	-0.95	0.84	-0.95	-0.44	0.84	0.93	0.63	-0.39
Operating Income	-0.78	-0.77	-0.69	0.78	-0.97	-0.94	-0.93	-0.96		0.99	0.99	-0.96	0.98	-0.95	-0.97	0.99	-0.89	0.99	0.51	-0.86	-0.88	-0.67	0.5
Net Income From Continuing Ops	-0.8	-0.79	-0.73	0.77	-0.96	-0.96	-0.95	-0.95	0.99		1.0	-0.93	0.98	-0.96	-0.95	1.0	-0.85	1.0	0.44	-0.87	-0.85	-0.64	0.55
Ebit	-0.76	-0.74	-0.67	0.77	-0.96	-0.94	-0.93	-0.94	0.99	1.0		-0.95	0.99	-0.94	-0.95	1.0	-0.87	1.0	0.53	-0.84	-0.84	-0.64	0.51
Research Development	0.69	0.66	0.59	-0.81	0.97	0.85	0.85	0.97	-0.96	-0.93	-0.95		-0.95	0.86	0.98	-0.94	0.88	-0.93	-0.59	0.78	0.89	0.61	-0.29
Ebitda	-0.68	-0.67	-0.57	0.73	-0.95	-0.89	-0.88	-0.93	0.98	0.98	0.99	-0.95		-0.89	-0.94	0.98	-0.87	0.98	0.61	-0.77	-0.79	-0.59	0.44
Cost Of Revenue	0.93	0.92	0.88	-0.8	0.9	1.0	0.99	0.91	-0.95	-0.96	-0.94	0.86	-0.89		0.9	-0.95	0.84	-0.96	-0.25	0.97	0.89	0.75	-0.71
Total Operating Expenses	0.75	0.73	0.66	-0.78	1.0	0.9	0.89	1.0	-0.97	-0.95	-0.95	0.98	-0.94	0.9		-0.95	0.85	-0.95	-0.49	0.82	0.92	0.62	-0.38
Income Before Tax	-0.79	-0.77	-0.71	0.77	-0.96	-0.95	-0.94	-0.95	0.99	1.0	1.0	-0.94	0.98	-0.95	-0.95		-0.86	1.0	0.47	-0.86	-0.85	-0.64	0.54
Total Other Income Expense Net	0.75	0.73	0.58	-0.79	0.84	0.84	0.84	0.84	-0.89	-0.85	-0.87	0.88	-0.87	0.84	0.85	-0.86		-0.85	-0.57	0.82	0.75	0.88	-0.48
Net Income	-0.8	-0.79	-0.73	0.77	-0.96	-0.96	-0.95	-0.95	0.99	1.0	1.0	-0.93	0.98	-0.96	-0.95	1.0	-0.85		0.44	-0.87	-0.85	-0.64	0.55
Income Tax Expense	0.05	0.08	0.21	0.34	-0.5	-0.26	-0.28	-0.44	0.51	0.44	0.53	-0.59	0.61	-0.25	-0.49	0.47	-0.57	0.44		-0.1	-0.29	-0.2	-0.11
Reconciled Depreciation	0.98	0.98	0.94	-0.83	0.8	0.97	0.96	0.84	-0.86	-0.87	-0.84	0.78	-0.77	0.97	0.82	-0.86	0.82	-0.87	-0.1		0.87	0.84	-0.75
Selling And Marketing Expenses	0.81	0.79	0.8	-0.85	0.9	0.89	0.89	0.93	-0.88	-0.85	-0.84	0.89	-0.79	0.89	0.92	-0.85	0.75	-0.85	-0.29	0.87		0.61	-0.46
Non Operating Income Net Other	0.84	0.83	0.68	-0.65	0.59	0.75	0.75	0.63	-0.67	-0.64	-0.64	0.61	-0.59	0.75	0.62	-0.64	0.88	-0.64	-0.2	0.84	0.61		-0.66
Non Recurring	-0.76	-0.77	-0.76	0.53	-0.37	-0.73	-0.74	-0.39	0.5	0.55	0.51	-0.29	0.44	-0.71	-0.38	0.54	-0.48	0.55	-0.11	-0.75	-0.46	-0.66

Click cells to compare fundamentals

Twist Bioscience Account Relationship Matchups

Twist Bioscience income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Tax Provision	382K	(1.9M)	(10.4M)	1.2M	560K	588K
Net Interest Income	712K	68K	3.0M	14.4M	15.3M	16.1M
Interest Income	1.5M	435K	3.1M	14.4M	15.3M	16.1M
Depreciation And Amortization	6.7M	12.0M	2.0M	29.3M	31.4M	33.0M
Interest Expense	787K	367K	80K	5K	29K	27.6K
Selling General Administrative	102.1M	133.4M	210.5M	186.8M	218.4M	124.4M
Total Revenue	90.1M	132.3M	203.6M	245.1M	313.0M	328.6M
Gross Profit	28.7M	51.7M	84.2M	89.7M	133.3M	140.0M
Other Operating Expenses	207.7M	285.6M	452.6M	462.3M	533.8M	283.1M
Operating Income	(117.6M)	(153.3M)	(249.0M)	(217.2M)	(220.8M)	(209.8M)
Net Income From Continuing Ops	(139.9M)	(152.1M)	(217.9M)	(204.6M)	(208.7M)	(219.2M)
Ebit	(138.8M)	(155.9M)	(249.0M)	(203.5M)	(208.1M)	(218.5M)
Research Development	43.0M	69.1M	120.3M	106.9M	90.9M	64.0M
Ebitda	(132.1M)	(143.9M)	(247.0M)	(174.2M)	(176.7M)	(185.5M)
Cost Of Revenue	61.4M	80.6M	119.3M	155.4M	179.6M	188.6M
Total Operating Expenses	146.3M	205.0M	333.3M	306.9M	354.2M	196.4M
Income Before Tax	(139.5M)	(154.0M)	(228.3M)	(203.5M)	(208.2M)	(218.6M)
Total Other Income Expense Net	530K	(1.3M)	20.7M	13.7M	12.7M	13.3M
Net Income Applicable To Common Shares	(107.7M)	(139.9M)	(152.1M)	(217.9M)	(196.1M)	(186.3M)
Net Income	(139.9M)	(152.1M)	(217.9M)	(204.6M)	(208.7M)	(219.2M)
Income Tax Expense	382K	(1.9M)	(10.4M)	1.2M	560K	588K
Reconciled Depreciation	6.7M	9.8M	16.5M	29.3M	31.4M	33.0M
Selling And Marketing Expenses	1.2M	2.5M	2.4M	2.9M	3.3M	2.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Twist Stock Analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Twist Historical Income Statement

About Twist Income Statement Analysis

Twist Bioscience Income Statement Chart

Total Revenue

Other Operating Expenses

Twist Bioscience income statement Correlations

Twist Bioscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Twist Bioscience income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Twist Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Interest Income	+ 1.0	Net Interest Income
Total Operating Expenses	+ 1.0	Selling General Administrative
Gross Profit	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Net Income From Continuing Ops

Total Operating Expenses	- 0.97	Operating Income
Operating Income	- 0.97	Selling General Administrative
Net Income	- 0.96	Cost Of Revenue
Cost Of Revenue	- 0.96	Net Income From Continuing Ops
Research Development	- 0.96	Operating Income
Operating Income	- 0.96	Other Operating Expenses